This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

reputable news agency

proofread

Postpartum low-dose esketamine aids moms with prenatal depression

Postpartum low-dose esketamine aids moms with prenatal depression

A single low dose of esketamine after childbirth reduces depressive episodes at 42 days postpartum among mothers with prenatal depression, according to a study published online April 10 in The BMJ.

Shuo Wang, M.D., from Peking University First Hospital in Beijing, and colleagues conducted a randomized, with two parallel arms involving 364 mothers aged 18 years and older from five tertiary care hospitals in China with at least mild prenatal depression. Participants were randomly assigned to receive 0.2 mg/kg esketamine or placebo infused intravenously over 40 minutes after childbirth (180 and 181 women, respectively).

The researchers found that a was observed in 6.7 and 25.4 percent of mothers in the esketamine and placebo groups, respectively, at 42 days postpartum (relative risk, 0.26). The esketamine group had lower scores on the Edinburgh Postnatal Depression Scale at seven days (median difference, −3) and 42 days (median difference, −3).

The esketamine group also had lower Hamilton Depression Rating Scale scores at 42 days postpartum (median difference, −4). The esketamine group had a higher incidence of neuropsychiatric adverse events (45.1 versus 22.0 percent); however, the symptoms lasted less than one day and did not require .

"Low-dose esketamine should be considered in mothers with symptoms of prenatal depression," the authors write.

More information: Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial, The BMJ (2024). doi.org/10.1136/bmj-2023-078218

Journal information: British Medical Journal (BMJ)

Copyright © 2024 HealthDay. All rights reserved.

Citation: Postpartum low-dose esketamine aids moms with prenatal depression (2024, April 20) retrieved 22 May 2024 from https://medicalxpress.com/news/2024-04-postpartum-dose-esketamine-aids-moms.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study finds esketamine injection just after childbirth reduces depression in new mothers

0 shares

Feedback to editors